Comments
Dr Reddy’s Laboratories today announced that it has launched Decitabine for Injection (50mg), a therapeutic equivalent generic version of Dacogen® (Decitabine for Injection) in the US market on Thursday.
This follows approval by the United States Food & Drug Administration (USFDA) of Dr Reddy’s Abbreviated New Drug Application for Decitabine for Injection.
The Dacogen® brand has US sales of approximately $260 million MAT for the 12 months ending in July 2013 according to IMS Health, a release from the Hyderabad-based pharma major said.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.